NLRP3 and asthma: These findings suggest that increased pre-priming to NLRP3 inflammasome-mediated IL-1β release by systemic immune cells is associated with increased neutrophilic airway inflammation and lower lung function in asthma in our cohort comprised of patients with neutrophilic and eosinophilic disease phenotypes.